MAXI-TUSS CD (CHLORPHENIRAMINE MALEATE, CODEINE PHOSPHATE, AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [MCR AMERICAN PHARMACEUTICALS, INC.]

MAXI-TUSS CD (CHLORPHENIRAMINE MALEATE, CODEINE PHOSPHATE, AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [MCR AMERICAN PHARMACEUTICALS, INC.]
PDF | XML

NDC 58605-303-10, 58605-303-16
Set ID e03294a3-1b3e-4d24-ac35-eca00a19db3d
Category HUMAN OTC DRUG LABEL
Packager MCR American Pharmaceuticals, Inc.
Generic Name
Product Class alpha-1 Adrenergic Agonist
Product Number
Application Number PART341
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • ACTIVE INGREDIENT

    Active Ingredients (in each 5 mL teaspoonful)Purpose
    Chlorpheniramine Maleate 4 mgAntihistamine
    Codeine Phosphate 10 mgCough Suppressant
    Phenylephrine HCl 10 mgNasal Decongestant
  • Uses

    temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

    • cough due to minor throat and bronchial irritation
    • runny nose
    • sneezing
    • itching of the nose or throat
    • itchy, watery eyes
    • nasal congestion
    • reduces swelling of nasal passages
    • calms the cough control center and relieves coughing
  • Warnings

    • Do not exceed recommended dosage.
    • A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor.
    • Adults and children who have a chronic pulmonary disease or shortness of breath, or children who are taking other drugs, should not take this product unless directed by a doctor.

    Do not use this product

    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

    Ask a doctor before use if you have

    • a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or where cough is accompanied by excessive phlegm
    • a breathing problem such as emphysema or chronic bronchitis
    • glaucoma
    • heart disease
    • high blood pressure
    • thyroid disease
    • diabetes mellitus
    • difficulty in urination due to enlargement of the prostate gland

    Ask a doctor before use if you are taking sedatives or tranquilizers

    When using this product

    • excitability may occur, especially in children
    • may cause marked drowsiness
    • alcohol, sedatives and tranquilizers may increase drowsiness
    • avoid alcoholic beverages
    • use caution when driving a motor vehicle or operating machinery
    • may cause or aggravate constipation

    Stop use and ask a doctor if

    • nervousness, dizziness, or sleeplessness occur
    • if symptoms do not improve within 7 days or are accompanied by fever, consult a doctor

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children.

    In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

  • Directions

    Do not exceed recommended dosage.

    Adults and children 12 years of age and over:1 teaspoonful every 4 hours, not to exceed 6 teaspoonfuls in 24 hours, or as directed by a doctor
    Children 6 to under 12 years of age:½ teaspoonful every 4 hours, not to exceed 3 teaspoonfuls in 24 hours, or as directed by a doctor
    Children under 6 years of age:Consult a doctor
  • Other information

    Store at 59° - 86°F (15° - 30°C)

  • Inactive ingredients

    Citric acid, flavor, methylparaben, potassium citrate, potassium sorbate, propylparaben, propylene glycol, purified water, sorbitol, sucralose

  • Questions or Comments?

    Call (352) 754-8587

  • PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label

    NDC 58605-303-16

    Maxi-Tuss CD

    Antihistamine ◾ Cough Suppressant
    Nasal Decongestant

    CV

    Each teaspoonful (5 mL) contains:
    Chlorpheniramine Maleate 4 mg
    Codeine Phosphate 10 mg
    Phenylephrine HCl 10 mg

    Grape Flavor

    Alcohol Free ◾ Gluten Free ◾ Sugar Free

    Caution: For manufacturing, processing, or
    repackaging. This is a bulk container; not
    intended for household use.

    Tamper evident by foil seal under cap.
    Do not use if foil seal is broken or missing.

    Lot:
    Exp Date:

    16 fl oz (473 mL)

    Principal Display Panel - 473 mL Bottle Label
  • INGREDIENTS AND APPEARANCE
    MAXI-TUSS CD 
    chlorpheniramine maleate, codeine phosphate, and phenylephrine hydrochloride liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58605-303
    Route of AdministrationORALDEA ScheduleCV    
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CHLORPHENIRAMINE MALEATE (UNII: V1Q0O9OJ9Z) (CHLORPHENIRAMINE - UNII:3U6IO1965U) CHLORPHENIRAMINE MALEATE4 mg  in 5 mL
    CODEINE PHOSPHATE (UNII: GSL05Y1MN6) (CODEINE ANHYDROUS - UNII:UX6OWY2V7J) CODEINE PHOSPHATE10 mg  in 5 mL
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    Methylparaben (UNII: A2I8C7HI9T)  
    Potassium Citrate (UNII: EE90ONI6FF)  
    Potassium Sorbate (UNII: 1VPU26JZZ4)  
    Propylparaben (UNII: Z8IX2SC1OH)  
    Propylene Glycol (UNII: 6DC9Q167V3)  
    Water (UNII: 059QF0KO0R)  
    Sorbitol (UNII: 506T60A25R)  
    Sucralose (UNII: 96K6UQ3ZD4)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorGRAPEImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:58605-303-16473 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product04/01/2018
    2NDC:58605-303-1010 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product04/01/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34104/01/2018
    Labeler - MCR American Pharmaceuticals, Inc. (783383011)
    Establishment
    NameAddressID/FEIBusiness Operations
    MCR American Pharmaceuticals, Inc.783383011MANUFACTURE(58605-303)

Related Drugs